Telomere maintaining germline and somatic variants in thyroid cancer and melanoma
S. Liyanarachchi, P. L. Brock, W. Li, T. T. Nieminen, N. Pozdeyev, B. R. Haugen, H. C. McCrary, B. Salhia, K. Jensen, A. R. Naqash, V. Kaur, J. Farlow, M. D. Ringel npj Precision Oncology
· Springer Nature
· 2026-11-12
· DOI: 10.1038/s41698-026-01758-7
Аннотация
npj Precision Oncology, Published online: 12 November 2026; doi:10.1038/s41698-026-01758-7 Telomere maintaining germline and somatic variants in thyroid cancer and melanoma
S. Liyanarachchi, P. L. Brock, W. Li, T. T. Nieminen, N. Pozdeyev, B. R. Haugen et al. Telomere maintaining germline and somatic variants in thyroid cancer and melanoma. // npj Precision Oncology. – 2026. – DOI: 10.1038/s41698-026-01758-7. – URL: https://www.nature.com/articles/s41698-026-01758-7
S. Liyanarachchi, P. L. Brock, W. Li, T. T. Nieminen, N. Pozdeyev, B. R. Haugen, H. C. McCrary, B. Salhia, K. Jensen, A. R. Naqash, V. Kaur, J. Farlow, & M. D. Ringel (2026). Telomere maintaining germline and somatic variants in thyroid cancer and melanoma. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01758-7
S. Liyanarachchi, et al. “Telomere maintaining germline and somatic variants in thyroid cancer and melanoma.” npj Precision Oncology, 2026. doi:10.1038/s41698-026-01758-7.
@article{Liyanarachchi2026,
title = {Telomere maintaining germline and somatic variants in thyroid cancer and melanoma},
author = {Liyanarachchi, S. and Brock, P. L. and Li, W. and Nieminen, T. T. and Pozdeyev, N. and Haugen, B. R. and McCrary, H. C. and Salhia, B. and Jensen, K. and Naqash, A. R. and Kaur, V. and Farlow, J. and Ringel, M. D.},
journal = {npj Precision Oncology},
year = {2026},
doi = {10.1038/s41698-026-01758-7},
url = {https://www.nature.com/articles/s41698-026-01758-7}
}
Nature Reviews Cancer, Published online: 19 November 2026; doi:10.1038/s41568-026-01001-2 In this Journal Club, Chien-Han Kao and Ruey-Hwa Chen discuss a study showing that tumours use both de novo purine biosynthesis and purine salvage...
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01779-2 Targeting SMYD3 in cancer-associated fibroblasts relieves immune suppression and improves anti-PD-L1 response in HPV-negative HNSCC
npj Precision Oncology, Published online: 19 November 2026; doi:10.1038/s41698-026-01786-3 Postoperative timing effects on AI-based resection-cavity segmentation in glioma: multi-site evaluation and relevance assessment